Citigroup »

Protagonist Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.7M 73k 22.92
2023-09-30 $2.5M 148k 16.64
2023-03-31 $5.0M 218k 23.00
2022-12-31 $1.6M 148k 10.91
2022-09-30 $2.7M 315k 8.43
2021-12-31 $4.7M 138k 34.20
2021-03-31 $2.5M 96k 25.90
2020-12-31 $196k 9.7k 20.19
2020-09-30 $47k 2.4k 19.49
2020-06-30 $1.1M 65k 17.66
2020-03-31 $50k 7.0k 7.12
2019-12-31 $40k 5.6k 7.09
2019-09-30 $8.0k 697 11.54
2019-06-30 $50k 4.1k 12.22
2019-03-31 $319k 25k 12.58
2018-06-30 $76k 13k 5.95
2018-03-31 $18k 2.0k 8.83
2017-12-31 $36k 1.8k 20.47
2017-06-30 $999 63 15.87
2017-03-31 $2.0k 144 13.89
2016-12-31 $168k 7.6k 22.00
2016-09-30 $13k 621 20.93